Article ID Journal Published Year Pages File Type
5698987 Clinical Oncology 2013 8 Pages PDF
Abstract
These interim data indicate no early evidence of detriment to quality of life, overall survival or QALYs for patients allocated to OSC alone. They provide key information for discussing the trial with patients and strengthen the argument for continuing QUARTZ to definitively answer this important clinical question.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , , , , , , , ,